This inventor holds 7 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Intron Biotechnology, Inc.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: In Hwang Kim: Innovator in Bacteriophage Research
Introduction
In Hwang Kim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of compositions and methods for inhibiting the proliferation of enterotoxigenic bacteria. With a total of six patents to his name, Kim's work is paving the way for innovative treatments against bacterial infections.
Latest Patents
Among his latest patents, Kim has developed compositions and methods for preventing or treating infections caused by enterotoxigenic bacteria. One of his notable inventions includes a composition that utilizes a Siphoviridae bacteriophage (Bac-FRP-5) capable of lysing enterotoxigenic cells. This composition is combined with a pharmaceutically acceptable carrier to enhance its effectiveness. Additionally, he has created a method for administering this bacteriophage to subjects, effectively targeting and lysing the harmful bacteria. Another significant patent involves a similar approach using a different Siphoviridae bacteriophage (Bac-FRP-4) to combat enterotoxigenic Bacteroides fragilis, showcasing his innovative strategies in bacteriophage therapy.
Career Highlights
In Hwang Kim is currently associated with Intron Biotechnology, Inc., where he continues to advance his research in bacteriophage applications. His work is instrumental in developing new therapeutic options for bacterial infections, which are increasingly important in the face of antibiotic resistance.
Collaborations
Kim collaborates with talented individuals in his field, including Seong Jun Yoon and Jee Soo Son. Their combined expertise contributes to the innovative research and development efforts at Intron Biotechnology, Inc.
Conclusion
In Hwang Kim is a pioneering inventor whose work in bacteriophage research is making significant strides in the fight against bacterial infections. His innovative patents and collaborations are setting the stage for future advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile